This page shows the latest Rebinyn news and features for those working in and with pharma, biotech and healthcare.
Plans to launch the haemophilia B treatment in the fourth quarter
launch Rebinyn (nonacog beta pegol or N9-GP) in the US until the first half of next year. ... We are confident that Rebinyn will become an important tool for physicians to help patients manage their bleeds.".
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
No results were found
Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...